Vietnam Procures its First Batch of Antiretroviral (ARV) Drugs through Social Health Insurance (SHI)

Speeches Shim

Thursday, October 25, 2018

In response to declining donor funds towards ARVs, Vietnam has committed to sustaining ARV procurement using its SHI Fund. In early October, with support from USAID’s Global Health Supply Chain - Procurement and Supply Management (GHSC-PSM) project, Vietnam’s Ministry of Health successfully bid for the first procurement of ARVs through SHI. The bid package, which is valued at approximately $5.9 million, will cover medication for 48,000 HIV/AIDS patients for an entire year - the number of HIV/AIDS patients estimated to be covered by SHI in 2019. The ARVs are expected to be available in January 2019. The bidding process also resulted in a 19 percent savings due to secured purchase prices now being both competitive and comparable to the price of drugs purchased by international donors.

So What? This SHI-funded ARV procurement demonstrates Vietnam’s strong commitment to undertake financial responsibility for its HIV/AIDS program. It represents a significant milestone in the Journey to Self-Reliance in the health sector.